nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Carmustine—malignant glioma	0.15	0.57	CbGbCtD
Ropinirole—CYP3A4—Temozolomide—malignant glioma	0.113	0.431	CbGbCtD
Ropinirole—HTR1D—meninx—malignant glioma	0.0283	0.106	CbGeAlD
Ropinirole—HTR1B—dura mater—malignant glioma	0.0269	0.101	CbGeAlD
Ropinirole—HTR1D—dura mater—malignant glioma	0.026	0.0973	CbGeAlD
Ropinirole—HTR2C—choroid plexus—malignant glioma	0.0219	0.0819	CbGeAlD
Ropinirole—DRD3—telencephalic ventricle—malignant glioma	0.0115	0.0432	CbGeAlD
Ropinirole—HTR2A—choroid plexus—malignant glioma	0.011	0.0411	CbGeAlD
Ropinirole—DRD1—telencephalic ventricle—malignant glioma	0.00827	0.0309	CbGeAlD
Ropinirole—HTR1B—telencephalic ventricle—malignant glioma	0.0067	0.025	CbGeAlD
Ropinirole—HTR1D—telencephalic ventricle—malignant glioma	0.00648	0.0242	CbGeAlD
Ropinirole—HTR2C—telencephalic ventricle—malignant glioma	0.00642	0.024	CbGeAlD
Ropinirole—HTR2A—cerebellar cortex—malignant glioma	0.00554	0.0207	CbGeAlD
Ropinirole—HTR1A—telencephalic ventricle—malignant glioma	0.0054	0.0202	CbGeAlD
Ropinirole—DRD2—telencephalic ventricle—malignant glioma	0.00488	0.0183	CbGeAlD
Ropinirole—HTR2A—pons—malignant glioma	0.00391	0.0146	CbGeAlD
Ropinirole—HTR2A—vertebral column—malignant glioma	0.00388	0.0145	CbGeAlD
Ropinirole—HTR1B—blood vessel—malignant glioma	0.00331	0.0124	CbGeAlD
Ropinirole—HTR2A—telencephalic ventricle—malignant glioma	0.00322	0.012	CbGeAlD
Ropinirole—HTR1D—blood vessel—malignant glioma	0.00321	0.012	CbGeAlD
Ropinirole—HTR2A—pineal body—malignant glioma	0.00279	0.0104	CbGeAlD
Ropinirole—DRD5—telencephalon—malignant glioma	0.0026	0.00971	CbGeAlD
Ropinirole—DRD1—brainstem—malignant glioma	0.00224	0.00836	CbGeAlD
Ropinirole—DRD1—telencephalon—malignant glioma	0.00198	0.00742	CbGeAlD
Ropinirole—Menorrhagia—Temozolomide—malignant glioma	0.0019	0.0054	CcSEcCtD
Ropinirole—Herpes zoster—Temozolomide—malignant glioma	0.00187	0.00531	CcSEcCtD
Ropinirole—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00187	0.00531	CcSEcCtD
Ropinirole—Necrosis—Carmustine—malignant glioma	0.00186	0.00527	CcSEcCtD
Ropinirole—Scotoma—Temozolomide—malignant glioma	0.00185	0.00526	CcSEcCtD
Ropinirole—Abscess—Carmustine—malignant glioma	0.00184	0.00523	CcSEcCtD
Ropinirole—HTR1B—brainstem—malignant glioma	0.00181	0.00678	CbGeAlD
Ropinirole—Otitis media—Temozolomide—malignant glioma	0.00181	0.00513	CcSEcCtD
Ropinirole—Coagulopathy—Temozolomide—malignant glioma	0.00181	0.00513	CcSEcCtD
Ropinirole—Memory impairment—Temozolomide—malignant glioma	0.00179	0.00509	CcSEcCtD
Ropinirole—Hyperaesthesia—Temozolomide—malignant glioma	0.00179	0.00509	CcSEcCtD
Ropinirole—DRD4—brain—malignant glioma	0.00178	0.00665	CbGeAlD
Ropinirole—HTR1D—brainstem—malignant glioma	0.00175	0.00656	CbGeAlD
Ropinirole—HTR2C—brainstem—malignant glioma	0.00174	0.0065	CbGeAlD
Ropinirole—HTR2A—endothelium—malignant glioma	0.00173	0.00646	CbGeAlD
Ropinirole—Rigors—Temozolomide—malignant glioma	0.00172	0.00489	CcSEcCtD
Ropinirole—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00171	0.00486	CcSEcCtD
Ropinirole—Endocrine disorder—Temozolomide—malignant glioma	0.0017	0.00482	CcSEcCtD
Ropinirole—Speech disorder—Carmustine—malignant glioma	0.00169	0.00481	CcSEcCtD
Ropinirole—Liver injury—Temozolomide—malignant glioma	0.00167	0.00475	CcSEcCtD
Ropinirole—Speech disorder—Temozolomide—malignant glioma	0.00164	0.00465	CcSEcCtD
Ropinirole—Disturbance in attention—Temozolomide—malignant glioma	0.00162	0.00461	CcSEcCtD
Ropinirole—HTR1B—telencephalon—malignant glioma	0.00161	0.00601	CbGeAlD
Ropinirole—Amenorrhoea—Temozolomide—malignant glioma	0.0016	0.00455	CcSEcCtD
Ropinirole—HTR2A—blood vessel—malignant glioma	0.00159	0.00596	CbGeAlD
Ropinirole—Thinking abnormal—Carmustine—malignant glioma	0.00159	0.00452	CcSEcCtD
Ropinirole—DRD3—central nervous system—malignant glioma	0.00158	0.00589	CbGeAlD
Ropinirole—Viral infection—Temozolomide—malignant glioma	0.00156	0.00442	CcSEcCtD
Ropinirole—HTR1D—telencephalon—malignant glioma	0.00156	0.00582	CbGeAlD
Ropinirole—Leukocytosis—Carmustine—malignant glioma	0.00155	0.0044	CcSEcCtD
Ropinirole—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00155	0.00439	CcSEcCtD
Ropinirole—HTR2C—telencephalon—malignant glioma	0.00154	0.00576	CbGeAlD
Ropinirole—Herpes simplex—Temozolomide—malignant glioma	0.00153	0.00434	CcSEcCtD
Ropinirole—Gait disturbance—Carmustine—malignant glioma	0.00149	0.00424	CcSEcCtD
Ropinirole—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00149	0.00422	CcSEcCtD
Ropinirole—Coordination abnormal—Carmustine—malignant glioma	0.00148	0.00421	CcSEcCtD
Ropinirole—Hearing impaired—Temozolomide—malignant glioma	0.00148	0.0042	CcSEcCtD
Ropinirole—DRD5—central nervous system—malignant glioma	0.00148	0.00552	CbGeAlD
Ropinirole—Neck pain—Carmustine—malignant glioma	0.00147	0.00418	CcSEcCtD
Ropinirole—HTR1A—brainstem—malignant glioma	0.00146	0.00547	CbGeAlD
Ropinirole—Pulmonary embolism—Carmustine—malignant glioma	0.00146	0.00413	CcSEcCtD
Ropinirole—HTR2B—telencephalon—malignant glioma	0.00145	0.00542	CbGeAlD
Ropinirole—Gait disturbance—Temozolomide—malignant glioma	0.00144	0.00409	CcSEcCtD
Ropinirole—Respiratory failure—Temozolomide—malignant glioma	0.00143	0.00407	CcSEcCtD
Ropinirole—Coordination abnormal—Temozolomide—malignant glioma	0.00143	0.00407	CcSEcCtD
Ropinirole—DRD1—midbrain—malignant glioma	0.00143	0.00533	CbGeAlD
Ropinirole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00141	0.004	CcSEcCtD
Ropinirole—Pulmonary embolism—Temozolomide—malignant glioma	0.00141	0.004	CcSEcCtD
Ropinirole—Depressed level of consciousness—Carmustine—malignant glioma	0.00141	0.00399	CcSEcCtD
Ropinirole—Urinary incontinence—Carmustine—malignant glioma	0.00141	0.00399	CcSEcCtD
Ropinirole—Skin exfoliation—Carmustine—malignant glioma	0.00139	0.00395	CcSEcCtD
Ropinirole—Candida infection—Carmustine—malignant glioma	0.00139	0.00395	CcSEcCtD
Ropinirole—Neuropathy—Carmustine—malignant glioma	0.00137	0.00388	CcSEcCtD
Ropinirole—Influenza like illness—Temozolomide—malignant glioma	0.00137	0.00388	CcSEcCtD
Ropinirole—Urinary incontinence—Temozolomide—malignant glioma	0.00136	0.00386	CcSEcCtD
Ropinirole—Depressed level of consciousness—Temozolomide—malignant glioma	0.00136	0.00386	CcSEcCtD
Ropinirole—Skin exfoliation—Temozolomide—malignant glioma	0.00134	0.00381	CcSEcCtD
Ropinirole—Candida infection—Temozolomide—malignant glioma	0.00134	0.00381	CcSEcCtD
Ropinirole—Coma—Carmustine—malignant glioma	0.00133	0.00378	CcSEcCtD
Ropinirole—Vaginal infection—Temozolomide—malignant glioma	0.00133	0.00377	CcSEcCtD
Ropinirole—DRD2—brainstem—malignant glioma	0.00132	0.00494	CbGeAlD
Ropinirole—Neuropathy—Temozolomide—malignant glioma	0.00132	0.00375	CcSEcCtD
Ropinirole—Neoplasm—Carmustine—malignant glioma	0.00132	0.00374	CcSEcCtD
Ropinirole—Gynaecomastia—Carmustine—malignant glioma	0.0013	0.0037	CcSEcCtD
Ropinirole—Dry eye—Temozolomide—malignant glioma	0.0013	0.00369	CcSEcCtD
Ropinirole—HTR1A—telencephalon—malignant glioma	0.0013	0.00485	CbGeAlD
Ropinirole—DRD2—retina—malignant glioma	0.00127	0.00477	CbGeAlD
Ropinirole—Neoplasm—Temozolomide—malignant glioma	0.00127	0.00361	CcSEcCtD
Ropinirole—Abnormal vision—Carmustine—malignant glioma	0.00127	0.00361	CcSEcCtD
Ropinirole—Sepsis—Carmustine—malignant glioma	0.00126	0.00359	CcSEcCtD
Ropinirole—Mental disability—Carmustine—malignant glioma	0.00126	0.00359	CcSEcCtD
Ropinirole—DRD3—brain—malignant glioma	0.00125	0.00468	CbGeAlD
Ropinirole—Abnormal vision—Temozolomide—malignant glioma	0.00123	0.00348	CcSEcCtD
Ropinirole—Phlebitis—Carmustine—malignant glioma	0.00123	0.00348	CcSEcCtD
Ropinirole—Mental disability—Temozolomide—malignant glioma	0.00122	0.00347	CcSEcCtD
Ropinirole—Thrombophlebitis—Carmustine—malignant glioma	0.00122	0.00347	CcSEcCtD
Ropinirole—Diabetes mellitus—Carmustine—malignant glioma	0.00122	0.00345	CcSEcCtD
Ropinirole—HTR2C—medulla oblongata—malignant glioma	0.00121	0.00453	CbGeAlD
Ropinirole—Ear pain—Temozolomide—malignant glioma	0.0012	0.0034	CcSEcCtD
Ropinirole—Thrombophlebitis—Temozolomide—malignant glioma	0.00118	0.00335	CcSEcCtD
Ropinirole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00117	0.00333	CcSEcCtD
Ropinirole—DRD2—telencephalon—malignant glioma	0.00117	0.00438	CbGeAlD
Ropinirole—DRD5—brain—malignant glioma	0.00117	0.00438	CbGeAlD
Ropinirole—Eye pain—Carmustine—malignant glioma	0.00117	0.00332	CcSEcCtD
Ropinirole—HTR1B—midbrain—malignant glioma	0.00115	0.00432	CbGeAlD
Ropinirole—Gastroenteritis—Temozolomide—malignant glioma	0.00115	0.00327	CcSEcCtD
Ropinirole—Deafness—Temozolomide—malignant glioma	0.00114	0.00324	CcSEcCtD
Ropinirole—Vascular purpura—Temozolomide—malignant glioma	0.00114	0.00324	CcSEcCtD
Ropinirole—ADRA2C—telencephalon—malignant glioma	0.00114	0.00426	CbGeAlD
Ropinirole—Eye pain—Temozolomide—malignant glioma	0.00113	0.00321	CcSEcCtD
Ropinirole—DRD1—central nervous system—malignant glioma	0.00113	0.00422	CbGeAlD
Ropinirole—HTR1B—spinal cord—malignant glioma	0.00113	0.00421	CbGeAlD
Ropinirole—Amnesia—Carmustine—malignant glioma	0.00112	0.00319	CcSEcCtD
Ropinirole—Nasal congestion—Temozolomide—malignant glioma	0.00112	0.00318	CcSEcCtD
Ropinirole—HTR1D—midbrain—malignant glioma	0.00112	0.00418	CbGeAlD
Ropinirole—HTR2C—midbrain—malignant glioma	0.00111	0.00414	CbGeAlD
Ropinirole—Hot flush—Temozolomide—malignant glioma	0.00109	0.0031	CcSEcCtD
Ropinirole—Amnesia—Temozolomide—malignant glioma	0.00109	0.00309	CcSEcCtD
Ropinirole—Menopausal symptoms—Temozolomide—malignant glioma	0.00108	0.00307	CcSEcCtD
Ropinirole—HTR2C—spinal cord—malignant glioma	0.00108	0.00404	CbGeAlD
Ropinirole—Thirst—Temozolomide—malignant glioma	0.00107	0.00305	CcSEcCtD
Ropinirole—Hyponatraemia—Carmustine—malignant glioma	0.00106	0.00301	CcSEcCtD
Ropinirole—Purpura—Temozolomide—malignant glioma	0.00106	0.00301	CcSEcCtD
Ropinirole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00106	0.003	CcSEcCtD
Ropinirole—Diplopia—Carmustine—malignant glioma	0.00106	0.003	CcSEcCtD
Ropinirole—Diplopia—Temozolomide—malignant glioma	0.00102	0.0029	CcSEcCtD
Ropinirole—Face oedema—Carmustine—malignant glioma	0.00102	0.0029	CcSEcCtD
Ropinirole—Affect lability—Temozolomide—malignant glioma	0.00101	0.00285	CcSEcCtD
Ropinirole—Ataxia—Carmustine—malignant glioma	0.000994	0.00282	CcSEcCtD
Ropinirole—Face oedema—Temozolomide—malignant glioma	0.000986	0.0028	CcSEcCtD
Ropinirole—Mood swings—Temozolomide—malignant glioma	0.000968	0.00275	CcSEcCtD
Ropinirole—Hypokalaemia—Carmustine—malignant glioma	0.000962	0.00273	CcSEcCtD
Ropinirole—Ataxia—Temozolomide—malignant glioma	0.00096	0.00273	CcSEcCtD
Ropinirole—HTR2A—embryo—malignant glioma	0.000951	0.00356	CbGeAlD
Ropinirole—Dehydration—Temozolomide—malignant glioma	0.00095	0.0027	CcSEcCtD
Ropinirole—Dry skin—Temozolomide—malignant glioma	0.000936	0.00266	CcSEcCtD
Ropinirole—Muscular weakness—Carmustine—malignant glioma	0.000932	0.00265	CcSEcCtD
Ropinirole—HTR1A—midbrain—malignant glioma	0.000932	0.00348	CbGeAlD
Ropinirole—Hypokalaemia—Temozolomide—malignant glioma	0.00093	0.00264	CcSEcCtD
Ropinirole—Breast disorder—Temozolomide—malignant glioma	0.000923	0.00262	CcSEcCtD
Ropinirole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00092	0.00261	CcSEcCtD
Ropinirole—HTR1B—central nervous system—malignant glioma	0.000914	0.00342	CbGeAlD
Ropinirole—Dysphagia—Carmustine—malignant glioma	0.000913	0.00259	CcSEcCtD
Ropinirole—ADRA2A—telencephalon—malignant glioma	0.00091	0.0034	CbGeAlD
Ropinirole—HTR1A—spinal cord—malignant glioma	0.000909	0.0034	CbGeAlD
Ropinirole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000901	0.00256	CcSEcCtD
Ropinirole—Muscular weakness—Temozolomide—malignant glioma	0.000901	0.00256	CcSEcCtD
Ropinirole—ADRA2C—medulla oblongata—malignant glioma	0.000896	0.00335	CbGeAlD
Ropinirole—DRD1—brain—malignant glioma	0.000896	0.00335	CbGeAlD
Ropinirole—Abdominal distension—Temozolomide—malignant glioma	0.000889	0.00252	CcSEcCtD
Ropinirole—HTR1D—central nervous system—malignant glioma	0.000885	0.00331	CbGeAlD
Ropinirole—Dysphagia—Temozolomide—malignant glioma	0.000883	0.00251	CcSEcCtD
Ropinirole—HTR2C—central nervous system—malignant glioma	0.000876	0.00328	CbGeAlD
Ropinirole—HTR2A—brainstem—malignant glioma	0.000871	0.00326	CbGeAlD
Ropinirole—Sweating increased—Temozolomide—malignant glioma	0.00086	0.00244	CcSEcCtD
Ropinirole—Bronchitis—Temozolomide—malignant glioma	0.000849	0.00241	CcSEcCtD
Ropinirole—DRD2—midbrain—malignant glioma	0.000842	0.00315	CbGeAlD
Ropinirole—HTR2A—retina—malignant glioma	0.000841	0.00314	CbGeAlD
Ropinirole—Dysuria—Temozolomide—malignant glioma	0.000825	0.00234	CcSEcCtD
Ropinirole—Hyperglycaemia—Carmustine—malignant glioma	0.000824	0.00234	CcSEcCtD
Ropinirole—HTR2B—central nervous system—malignant glioma	0.000823	0.00308	CbGeAlD
Ropinirole—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00082	0.00233	CcSEcCtD
Ropinirole—Pneumonia—Carmustine—malignant glioma	0.000819	0.00233	CcSEcCtD
Ropinirole—ADRA2C—midbrain—malignant glioma	0.000819	0.00306	CbGeAlD
Ropinirole—Pollakiuria—Temozolomide—malignant glioma	0.000815	0.00232	CcSEcCtD
Ropinirole—Erectile dysfunction—Temozolomide—malignant glioma	0.000813	0.00231	CcSEcCtD
Ropinirole—Depression—Carmustine—malignant glioma	0.000812	0.00231	CcSEcCtD
Ropinirole—Photosensitivity reaction—Temozolomide—malignant glioma	0.000806	0.00229	CcSEcCtD
Ropinirole—Weight increased—Temozolomide—malignant glioma	0.000803	0.00228	CcSEcCtD
Ropinirole—ADRA2C—spinal cord—malignant glioma	0.000799	0.00299	CbGeAlD
Ropinirole—Weight decreased—Temozolomide—malignant glioma	0.000799	0.00227	CcSEcCtD
Ropinirole—Neuropathy peripheral—Carmustine—malignant glioma	0.000798	0.00227	CcSEcCtD
Ropinirole—Hyperglycaemia—Temozolomide—malignant glioma	0.000796	0.00226	CcSEcCtD
Ropinirole—CYP2D6—brainstem—malignant glioma	0.000794	0.00297	CbGeAlD
Ropinirole—Stomatitis—Carmustine—malignant glioma	0.000794	0.00225	CcSEcCtD
Ropinirole—Urinary tract infection—Carmustine—malignant glioma	0.000792	0.00225	CcSEcCtD
Ropinirole—Pneumonia—Temozolomide—malignant glioma	0.000792	0.00225	CcSEcCtD
Ropinirole—Infestation NOS—Temozolomide—malignant glioma	0.000787	0.00223	CcSEcCtD
Ropinirole—Infestation—Temozolomide—malignant glioma	0.000787	0.00223	CcSEcCtD
Ropinirole—Depression—Temozolomide—malignant glioma	0.000785	0.00223	CcSEcCtD
Ropinirole—HTR2A—telencephalon—malignant glioma	0.000773	0.00289	CbGeAlD
Ropinirole—Neuropathy peripheral—Temozolomide—malignant glioma	0.000772	0.00219	CcSEcCtD
Ropinirole—Stomatitis—Temozolomide—malignant glioma	0.000767	0.00218	CcSEcCtD
Ropinirole—Urinary tract infection—Temozolomide—malignant glioma	0.000765	0.00217	CcSEcCtD
Ropinirole—Hepatobiliary disease—Temozolomide—malignant glioma	0.000744	0.00211	CcSEcCtD
Ropinirole—Sinusitis—Temozolomide—malignant glioma	0.000738	0.0021	CcSEcCtD
Ropinirole—HTR1A—central nervous system—malignant glioma	0.000738	0.00276	CbGeAlD
Ropinirole—Haemoglobin—Carmustine—malignant glioma	0.000735	0.00209	CcSEcCtD
Ropinirole—Haemorrhage—Carmustine—malignant glioma	0.000731	0.00208	CcSEcCtD
Ropinirole—Hypoaesthesia—Carmustine—malignant glioma	0.000727	0.00207	CcSEcCtD
Ropinirole—Hallucination—Carmustine—malignant glioma	0.000727	0.00207	CcSEcCtD
Ropinirole—HTR1B—brain—malignant glioma	0.000726	0.00271	CbGeAlD
Ropinirole—HTR1A—cerebellum—malignant glioma	0.000721	0.0027	CbGeAlD
Ropinirole—Oedema peripheral—Carmustine—malignant glioma	0.00072	0.00205	CcSEcCtD
Ropinirole—Connective tissue disorder—Carmustine—malignant glioma	0.000718	0.00204	CcSEcCtD
Ropinirole—ADRA2A—medulla oblongata—malignant glioma	0.000715	0.00267	CbGeAlD
Ropinirole—Haemoglobin—Temozolomide—malignant glioma	0.00071	0.00202	CcSEcCtD
Ropinirole—Haemorrhage—Temozolomide—malignant glioma	0.000707	0.00201	CcSEcCtD
Ropinirole—Visual impairment—Carmustine—malignant glioma	0.000705	0.002	CcSEcCtD
Ropinirole—CYP2D6—telencephalon—malignant glioma	0.000705	0.00263	CbGeAlD
Ropinirole—Hypoaesthesia—Temozolomide—malignant glioma	0.000703	0.002	CcSEcCtD
Ropinirole—Hallucination—Temozolomide—malignant glioma	0.000703	0.002	CcSEcCtD
Ropinirole—HTR1D—brain—malignant glioma	0.000703	0.00263	CbGeAlD
Ropinirole—Pharyngitis—Temozolomide—malignant glioma	0.000701	0.00199	CcSEcCtD
Ropinirole—Urinary tract disorder—Temozolomide—malignant glioma	0.000698	0.00198	CcSEcCtD
Ropinirole—Oedema peripheral—Temozolomide—malignant glioma	0.000696	0.00198	CcSEcCtD
Ropinirole—HTR2C—brain—malignant glioma	0.000696	0.0026	CbGeAlD
Ropinirole—Connective tissue disorder—Temozolomide—malignant glioma	0.000694	0.00197	CcSEcCtD
Ropinirole—Urethral disorder—Temozolomide—malignant glioma	0.000693	0.00197	CcSEcCtD
Ropinirole—Eye disorder—Carmustine—malignant glioma	0.000683	0.00194	CcSEcCtD
Ropinirole—Visual impairment—Temozolomide—malignant glioma	0.000681	0.00193	CcSEcCtD
Ropinirole—Flushing—Carmustine—malignant glioma	0.000679	0.00193	CcSEcCtD
Ropinirole—DRD2—central nervous system—malignant glioma	0.000666	0.00249	CbGeAlD
Ropinirole—Eye disorder—Temozolomide—malignant glioma	0.00066	0.00187	CcSEcCtD
Ropinirole—Tinnitus—Temozolomide—malignant glioma	0.000659	0.00187	CcSEcCtD
Ropinirole—Cardiac disorder—Temozolomide—malignant glioma	0.000656	0.00186	CcSEcCtD
Ropinirole—Flushing—Temozolomide—malignant glioma	0.000656	0.00186	CcSEcCtD
Ropinirole—HTR2B—brain—malignant glioma	0.000654	0.00244	CbGeAlD
Ropinirole—ADRA2A—midbrain—malignant glioma	0.000653	0.00244	CbGeAlD
Ropinirole—Arrhythmia—Carmustine—malignant glioma	0.000653	0.00185	CcSEcCtD
Ropinirole—DRD2—cerebellum—malignant glioma	0.000651	0.00244	CbGeAlD
Ropinirole—ADRA2C—central nervous system—malignant glioma	0.000648	0.00242	CbGeAlD
Ropinirole—Alopecia—Carmustine—malignant glioma	0.000646	0.00183	CcSEcCtD
Ropinirole—Angiopathy—Temozolomide—malignant glioma	0.000641	0.00182	CcSEcCtD
Ropinirole—Mental disorder—Carmustine—malignant glioma	0.000641	0.00182	CcSEcCtD
Ropinirole—Immune system disorder—Temozolomide—malignant glioma	0.000638	0.00181	CcSEcCtD
Ropinirole—ADRA2A—spinal cord—malignant glioma	0.000637	0.00238	CbGeAlD
Ropinirole—Mediastinal disorder—Temozolomide—malignant glioma	0.000637	0.00181	CcSEcCtD
Ropinirole—Malnutrition—Carmustine—malignant glioma	0.000636	0.00181	CcSEcCtD
Ropinirole—Chills—Temozolomide—malignant glioma	0.000634	0.0018	CcSEcCtD
Ropinirole—ADRA2C—cerebellum—malignant glioma	0.000633	0.00237	CbGeAlD
Ropinirole—Alopecia—Temozolomide—malignant glioma	0.000624	0.00177	CcSEcCtD
Ropinirole—Mental disorder—Temozolomide—malignant glioma	0.000619	0.00176	CcSEcCtD
Ropinirole—Back pain—Carmustine—malignant glioma	0.000616	0.00175	CcSEcCtD
Ropinirole—Malnutrition—Temozolomide—malignant glioma	0.000615	0.00175	CcSEcCtD
Ropinirole—HTR2A—medulla oblongata—malignant glioma	0.000608	0.00227	CbGeAlD
Ropinirole—Dysgeusia—Temozolomide—malignant glioma	0.000602	0.00171	CcSEcCtD
Ropinirole—Vision blurred—Carmustine—malignant glioma	0.0006	0.0017	CcSEcCtD
Ropinirole—Tremor—Carmustine—malignant glioma	0.000596	0.00169	CcSEcCtD
Ropinirole—Back pain—Temozolomide—malignant glioma	0.000595	0.00169	CcSEcCtD
Ropinirole—Anaemia—Carmustine—malignant glioma	0.000588	0.00167	CcSEcCtD
Ropinirole—HTR1A—brain—malignant glioma	0.000586	0.00219	CbGeAlD
Ropinirole—Agitation—Carmustine—malignant glioma	0.000585	0.00166	CcSEcCtD
Ropinirole—Vision blurred—Temozolomide—malignant glioma	0.00058	0.00165	CcSEcCtD
Ropinirole—Tremor—Temozolomide—malignant glioma	0.000576	0.00164	CcSEcCtD
Ropinirole—Ill-defined disorder—Temozolomide—malignant glioma	0.000571	0.00162	CcSEcCtD
Ropinirole—Leukopenia—Carmustine—malignant glioma	0.00057	0.00162	CcSEcCtD
Ropinirole—Anaemia—Temozolomide—malignant glioma	0.000569	0.00161	CcSEcCtD
Ropinirole—Agitation—Temozolomide—malignant glioma	0.000565	0.0016	CcSEcCtD
Ropinirole—Angioedema—Temozolomide—malignant glioma	0.000562	0.0016	CcSEcCtD
Ropinirole—HTR2A—midbrain—malignant glioma	0.000555	0.00208	CbGeAlD
Ropinirole—Malaise—Temozolomide—malignant glioma	0.000555	0.00157	CcSEcCtD
Ropinirole—Vertigo—Temozolomide—malignant glioma	0.000553	0.00157	CcSEcCtD
Ropinirole—Convulsion—Carmustine—malignant glioma	0.000551	0.00157	CcSEcCtD
Ropinirole—Leukopenia—Temozolomide—malignant glioma	0.000551	0.00156	CcSEcCtD
Ropinirole—Hypertension—Carmustine—malignant glioma	0.00055	0.00156	CcSEcCtD
Ropinirole—Palpitations—Temozolomide—malignant glioma	0.000544	0.00154	CcSEcCtD
Ropinirole—HTR2A—spinal cord—malignant glioma	0.000542	0.00203	CbGeAlD
Ropinirole—Chest pain—Carmustine—malignant glioma	0.000542	0.00154	CcSEcCtD
Ropinirole—Myalgia—Carmustine—malignant glioma	0.000542	0.00154	CcSEcCtD
Ropinirole—Anxiety—Carmustine—malignant glioma	0.00054	0.00153	CcSEcCtD
Ropinirole—Cough—Temozolomide—malignant glioma	0.000537	0.00152	CcSEcCtD
Ropinirole—Convulsion—Temozolomide—malignant glioma	0.000533	0.00151	CcSEcCtD
Ropinirole—Hypertension—Temozolomide—malignant glioma	0.000531	0.00151	CcSEcCtD
Ropinirole—DRD2—brain—malignant glioma	0.000529	0.00198	CbGeAlD
Ropinirole—Confusional state—Carmustine—malignant glioma	0.000524	0.00149	CcSEcCtD
Ropinirole—Arthralgia—Temozolomide—malignant glioma	0.000524	0.00149	CcSEcCtD
Ropinirole—Myalgia—Temozolomide—malignant glioma	0.000524	0.00149	CcSEcCtD
Ropinirole—Anxiety—Temozolomide—malignant glioma	0.000522	0.00148	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00052	0.00148	CcSEcCtD
Ropinirole—Oedema—Carmustine—malignant glioma	0.000519	0.00147	CcSEcCtD
Ropinirole—Discomfort—Temozolomide—malignant glioma	0.000517	0.00147	CcSEcCtD
Ropinirole—ADRA2A—central nervous system—malignant glioma	0.000517	0.00193	CbGeAlD
Ropinirole—Infection—Carmustine—malignant glioma	0.000516	0.00147	CcSEcCtD
Ropinirole—ADRA2C—brain—malignant glioma	0.000514	0.00192	CbGeAlD
Ropinirole—Dry mouth—Temozolomide—malignant glioma	0.000512	0.00145	CcSEcCtD
Ropinirole—Thrombocytopenia—Carmustine—malignant glioma	0.000509	0.00144	CcSEcCtD
Ropinirole—Tachycardia—Carmustine—malignant glioma	0.000507	0.00144	CcSEcCtD
Ropinirole—Confusional state—Temozolomide—malignant glioma	0.000506	0.00144	CcSEcCtD
Ropinirole—ADRA2A—cerebellum—malignant glioma	0.000505	0.00189	CbGeAlD
Ropinirole—Oedema—Temozolomide—malignant glioma	0.000502	0.00143	CcSEcCtD
Ropinirole—Infection—Temozolomide—malignant glioma	0.000499	0.00142	CcSEcCtD
Ropinirole—Anorexia—Carmustine—malignant glioma	0.000495	0.00141	CcSEcCtD
Ropinirole—Nervous system disorder—Temozolomide—malignant glioma	0.000492	0.0014	CcSEcCtD
Ropinirole—Thrombocytopenia—Temozolomide—malignant glioma	0.000492	0.0014	CcSEcCtD
Ropinirole—Skin disorder—Temozolomide—malignant glioma	0.000488	0.00138	CcSEcCtD
Ropinirole—Hypotension—Carmustine—malignant glioma	0.000485	0.00138	CcSEcCtD
Ropinirole—Hyperhidrosis—Temozolomide—malignant glioma	0.000485	0.00138	CcSEcCtD
Ropinirole—Anorexia—Temozolomide—malignant glioma	0.000479	0.00136	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000473	0.00134	CcSEcCtD
Ropinirole—Insomnia—Carmustine—malignant glioma	0.00047	0.00133	CcSEcCtD
Ropinirole—Paraesthesia—Carmustine—malignant glioma	0.000466	0.00132	CcSEcCtD
Ropinirole—Dyspnoea—Carmustine—malignant glioma	0.000463	0.00132	CcSEcCtD
Ropinirole—Somnolence—Carmustine—malignant glioma	0.000462	0.00131	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000457	0.0013	CcSEcCtD
Ropinirole—Insomnia—Temozolomide—malignant glioma	0.000454	0.00129	CcSEcCtD
Ropinirole—Decreased appetite—Carmustine—malignant glioma	0.000452	0.00128	CcSEcCtD
Ropinirole—Paraesthesia—Temozolomide—malignant glioma	0.000451	0.00128	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000448	0.00127	CcSEcCtD
Ropinirole—Dyspnoea—Temozolomide—malignant glioma	0.000448	0.00127	CcSEcCtD
Ropinirole—Somnolence—Temozolomide—malignant glioma	0.000446	0.00127	CcSEcCtD
Ropinirole—Constipation—Carmustine—malignant glioma	0.000444	0.00126	CcSEcCtD
Ropinirole—Pain—Carmustine—malignant glioma	0.000444	0.00126	CcSEcCtD
Ropinirole—Dyspepsia—Temozolomide—malignant glioma	0.000442	0.00125	CcSEcCtD
Ropinirole—HTR2A—central nervous system—malignant glioma	0.00044	0.00164	CbGeAlD
Ropinirole—Decreased appetite—Temozolomide—malignant glioma	0.000436	0.00124	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000433	0.00123	CcSEcCtD
Ropinirole—Fatigue—Temozolomide—malignant glioma	0.000433	0.00123	CcSEcCtD
Ropinirole—HTR2A—cerebellum—malignant glioma	0.00043	0.00161	CbGeAlD
Ropinirole—Pain—Temozolomide—malignant glioma	0.000429	0.00122	CcSEcCtD
Ropinirole—Constipation—Temozolomide—malignant glioma	0.000429	0.00122	CcSEcCtD
Ropinirole—Feeling abnormal—Carmustine—malignant glioma	0.000428	0.00122	CcSEcCtD
Ropinirole—Gastrointestinal pain—Carmustine—malignant glioma	0.000425	0.00121	CcSEcCtD
Ropinirole—Feeling abnormal—Temozolomide—malignant glioma	0.000414	0.00117	CcSEcCtD
Ropinirole—Abdominal pain—Carmustine—malignant glioma	0.000411	0.00117	CcSEcCtD
Ropinirole—Body temperature increased—Carmustine—malignant glioma	0.000411	0.00117	CcSEcCtD
Ropinirole—Gastrointestinal pain—Temozolomide—malignant glioma	0.00041	0.00117	CcSEcCtD
Ropinirole—ADRA2A—brain—malignant glioma	0.00041	0.00153	CbGeAlD
Ropinirole—CYP3A4—central nervous system—malignant glioma	0.000407	0.00152	CbGeAlD
Ropinirole—CYP2D6—central nervous system—malignant glioma	0.0004	0.0015	CbGeAlD
Ropinirole—Urticaria—Temozolomide—malignant glioma	0.000399	0.00113	CcSEcCtD
Ropinirole—Abdominal pain—Temozolomide—malignant glioma	0.000397	0.00113	CcSEcCtD
Ropinirole—Body temperature increased—Temozolomide—malignant glioma	0.000397	0.00113	CcSEcCtD
Ropinirole—CYP2D6—cerebellum—malignant glioma	0.000391	0.00146	CbGeAlD
Ropinirole—Hypersensitivity—Carmustine—malignant glioma	0.000383	0.00109	CcSEcCtD
Ropinirole—Asthenia—Carmustine—malignant glioma	0.000373	0.00106	CcSEcCtD
Ropinirole—Hypersensitivity—Temozolomide—malignant glioma	0.00037	0.00105	CcSEcCtD
Ropinirole—Asthenia—Temozolomide—malignant glioma	0.00036	0.00102	CcSEcCtD
Ropinirole—Diarrhoea—Carmustine—malignant glioma	0.000355	0.00101	CcSEcCtD
Ropinirole—Pruritus—Temozolomide—malignant glioma	0.000355	0.00101	CcSEcCtD
Ropinirole—HTR2A—brain—malignant glioma	0.000349	0.0013	CbGeAlD
Ropinirole—Dizziness—Carmustine—malignant glioma	0.000344	0.000975	CcSEcCtD
Ropinirole—Diarrhoea—Temozolomide—malignant glioma	0.000343	0.000975	CcSEcCtD
Ropinirole—Dizziness—Temozolomide—malignant glioma	0.000332	0.000943	CcSEcCtD
Ropinirole—Vomiting—Carmustine—malignant glioma	0.00033	0.000938	CcSEcCtD
Ropinirole—Rash—Carmustine—malignant glioma	0.000328	0.00093	CcSEcCtD
Ropinirole—Dermatitis—Carmustine—malignant glioma	0.000327	0.000929	CcSEcCtD
Ropinirole—Headache—Carmustine—malignant glioma	0.000325	0.000924	CcSEcCtD
Ropinirole—Vomiting—Temozolomide—malignant glioma	0.000319	0.000906	CcSEcCtD
Ropinirole—CYP2D6—brain—malignant glioma	0.000318	0.00119	CbGeAlD
Ropinirole—Rash—Temozolomide—malignant glioma	0.000317	0.000899	CcSEcCtD
Ropinirole—Dermatitis—Temozolomide—malignant glioma	0.000316	0.000898	CcSEcCtD
Ropinirole—Headache—Temozolomide—malignant glioma	0.000314	0.000893	CcSEcCtD
Ropinirole—Nausea—Carmustine—malignant glioma	0.000309	0.000876	CcSEcCtD
Ropinirole—Nausea—Temozolomide—malignant glioma	0.000298	0.000847	CcSEcCtD
Ropinirole—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	1.06e-05	9.04e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APC—malignant glioma	1.06e-05	9.03e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	1.06e-05	9.03e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.06e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.06e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MDM2—malignant glioma	1.06e-05	9e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RAF1—malignant glioma	1.05e-05	8.97e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.05e-05	8.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGF—malignant glioma	1.05e-05	8.93e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.05e-05	8.92e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—malignant glioma	1.05e-05	8.9e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—malignant glioma	1.04e-05	8.88e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB2—malignant glioma	1.04e-05	8.87e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	1.04e-05	8.87e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CD—malignant glioma	1.04e-05	8.87e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.04e-05	8.86e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTEN—malignant glioma	1.04e-05	8.85e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.03e-05	8.8e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTEN—malignant glioma	1.03e-05	8.8e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	1.03e-05	8.79e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—STAT3—malignant glioma	1.03e-05	8.79e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	1.03e-05	8.78e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—malignant glioma	1.03e-05	8.78e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	8.76e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	1.03e-05	8.76e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MDM2—malignant glioma	1.03e-05	8.76e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTP1—malignant glioma	1.03e-05	8.74e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTEN—malignant glioma	1.03e-05	8.73e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	1.02e-05	8.73e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RAF1—malignant glioma	1.02e-05	8.72e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—KRAS—malignant glioma	1.02e-05	8.68e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.02e-05	8.64e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	1.01e-05	8.63e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—malignant glioma	1.01e-05	8.63e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—KRAS—malignant glioma	1e-05	8.54e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	1e-05	8.52e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—malignant glioma	1e-05	8.52e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAT—malignant glioma	9.98e-06	8.5e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—FGF2—malignant glioma	9.97e-06	8.49e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—BRAF—malignant glioma	9.97e-06	8.49e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—malignant glioma	9.95e-06	8.48e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—BCHE—malignant glioma	9.95e-06	8.47e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—malignant glioma	9.95e-06	8.47e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	9.94e-06	8.47e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—malignant glioma	9.94e-06	8.46e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—malignant glioma	9.88e-06	8.42e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—malignant glioma	9.85e-06	8.39e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CASP3—malignant glioma	9.85e-06	8.39e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—malignant glioma	9.84e-06	8.37e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.83e-06	8.37e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—FGF2—malignant glioma	9.81e-06	8.35e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—malignant glioma	9.75e-06	8.3e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—malignant glioma	9.74e-06	8.29e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CB—malignant glioma	9.72e-06	8.27e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT2—malignant glioma	9.7e-06	8.26e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	9.66e-06	8.23e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—malignant glioma	9.63e-06	8.2e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	9.61e-06	8.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	9.6e-06	8.17e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—malignant glioma	9.59e-06	8.17e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	9.55e-06	8.13e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—malignant glioma	9.53e-06	8.12e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—malignant glioma	9.51e-06	8.1e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—malignant glioma	9.5e-06	8.08e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—malignant glioma	9.46e-06	8.06e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—malignant glioma	9.45e-06	8.04e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NCOR1—malignant glioma	9.43e-06	8.03e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—malignant glioma	9.38e-06	7.99e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—malignant glioma	9.38e-06	7.99e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	9.37e-06	7.98e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MDM2—malignant glioma	9.33e-06	7.94e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	9.32e-06	7.94e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—malignant glioma	9.31e-06	7.93e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RAF1—malignant glioma	9.3e-06	7.92e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—malignant glioma	9.29e-06	7.91e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	9.29e-06	7.91e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—malignant glioma	9.26e-06	7.88e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—malignant glioma	9.26e-06	7.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	9.23e-06	7.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	9.22e-06	7.85e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—malignant glioma	9.2e-06	7.83e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—malignant glioma	9.2e-06	7.83e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—malignant glioma	9.2e-06	7.83e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—malignant glioma	9.19e-06	7.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MDM2—malignant glioma	9.18e-06	7.82e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—malignant glioma	9.17e-06	7.81e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—malignant glioma	9.16e-06	7.8e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RAF1—malignant glioma	9.15e-06	7.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	9.13e-06	7.77e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CB—malignant glioma	9.08e-06	7.73e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAV1—malignant glioma	9.07e-06	7.73e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—malignant glioma	9.05e-06	7.71e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	9.03e-06	7.69e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—malignant glioma	9.01e-06	7.67e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—malignant glioma	9.01e-06	7.67e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—malignant glioma	8.99e-06	7.65e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—malignant glioma	8.96e-06	7.62e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—malignant glioma	8.94e-06	7.61e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—malignant glioma	8.93e-06	7.61e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	8.93e-06	7.61e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FGF2—malignant glioma	8.93e-06	7.6e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—malignant glioma	8.89e-06	7.57e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—malignant glioma	8.86e-06	7.55e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—malignant glioma	8.72e-06	7.43e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—malignant glioma	8.72e-06	7.42e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—malignant glioma	8.7e-06	7.4e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—malignant glioma	8.67e-06	7.38e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—malignant glioma	8.65e-06	7.36e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—malignant glioma	8.63e-06	7.35e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—malignant glioma	8.58e-06	7.31e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—malignant glioma	8.52e-06	7.25e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—malignant glioma	8.46e-06	7.2e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	8.45e-06	7.19e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—malignant glioma	8.45e-06	7.19e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	8.43e-06	7.18e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—malignant glioma	8.43e-06	7.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—malignant glioma	8.4e-06	7.15e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	8.39e-06	7.14e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	8.36e-06	7.12e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MDM2—malignant glioma	8.35e-06	7.11e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—malignant glioma	8.35e-06	7.11e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—malignant glioma	8.34e-06	7.1e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—malignant glioma	8.33e-06	7.09e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAF1—malignant glioma	8.32e-06	7.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	8.29e-06	7.06e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—malignant glioma	8.28e-06	7.05e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	8.27e-06	7.04e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.26e-06	7.04e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	8.23e-06	7.01e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—malignant glioma	8.22e-06	6.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—malignant glioma	8.2e-06	6.98e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—malignant glioma	8.17e-06	6.96e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—malignant glioma	8.14e-06	6.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	8.13e-06	6.92e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—malignant glioma	8.07e-06	6.87e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—malignant glioma	8.03e-06	6.84e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—malignant glioma	8e-06	6.81e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—malignant glioma	7.99e-06	6.8e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—malignant glioma	7.98e-06	6.79e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—malignant glioma	7.98e-06	6.79e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—malignant glioma	7.95e-06	6.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—malignant glioma	7.92e-06	6.74e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—malignant glioma	7.89e-06	6.72e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—malignant glioma	7.88e-06	6.71e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—malignant glioma	7.87e-06	6.7e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—malignant glioma	7.84e-06	6.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	7.81e-06	6.65e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	7.81e-06	6.65e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	7.77e-06	6.62e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—malignant glioma	7.76e-06	6.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—malignant glioma	7.73e-06	6.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—malignant glioma	7.72e-06	6.57e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAT—malignant glioma	7.71e-06	6.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—malignant glioma	7.69e-06	6.55e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—malignant glioma	7.69e-06	6.54e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—malignant glioma	7.65e-06	6.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	7.54e-06	6.42e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—malignant glioma	7.53e-06	6.41e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—malignant glioma	7.52e-06	6.41e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—malignant glioma	7.52e-06	6.4e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—malignant glioma	7.47e-06	6.36e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—malignant glioma	7.46e-06	6.35e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—malignant glioma	7.42e-06	6.32e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—malignant glioma	7.39e-06	6.29e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.34e-06	6.25e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—malignant glioma	7.33e-06	6.24e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—malignant glioma	7.29e-06	6.21e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NCOR1—malignant glioma	7.28e-06	6.2e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.27e-06	6.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—malignant glioma	7.26e-06	6.18e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—malignant glioma	7.23e-06	6.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—malignant glioma	7.22e-06	6.15e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—malignant glioma	7.18e-06	6.12e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—malignant glioma	7.11e-06	6.05e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—malignant glioma	7.09e-06	6.04e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—malignant glioma	7.09e-06	6.03e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—malignant glioma	7.06e-06	6.01e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—malignant glioma	7.03e-06	5.98e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—malignant glioma	7.02e-06	5.98e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—malignant glioma	7.02e-06	5.97e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—malignant glioma	7e-06	5.96e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—malignant glioma	7e-06	5.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—malignant glioma	6.97e-06	5.94e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—malignant glioma	6.9e-06	5.88e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—malignant glioma	6.9e-06	5.88e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—malignant glioma	6.86e-06	5.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	6.85e-06	5.83e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—malignant glioma	6.83e-06	5.81e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—malignant glioma	6.76e-06	5.75e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—malignant glioma	6.76e-06	5.75e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—malignant glioma	6.65e-06	5.66e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—malignant glioma	6.64e-06	5.65e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	6.53e-06	5.56e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—malignant glioma	6.52e-06	5.55e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—malignant glioma	6.41e-06	5.46e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—malignant glioma	6.38e-06	5.43e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—malignant glioma	6.35e-06	5.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	6.34e-06	5.4e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.33e-06	5.39e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—malignant glioma	6.32e-06	5.38e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	6.3e-06	5.37e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—malignant glioma	6.28e-06	5.35e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—malignant glioma	6.28e-06	5.34e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—malignant glioma	6.27e-06	5.34e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	6.27e-06	5.34e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—malignant glioma	6.16e-06	5.24e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	6.1e-06	5.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—malignant glioma	6.1e-06	5.19e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—malignant glioma	6.07e-06	5.16e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—malignant glioma	6.02e-06	5.13e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—malignant glioma	5.99e-06	5.1e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—malignant glioma	5.96e-06	5.07e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—malignant glioma	5.93e-06	5.05e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—malignant glioma	5.93e-06	5.05e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—malignant glioma	5.92e-06	5.04e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—malignant glioma	5.91e-06	5.03e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—malignant glioma	5.9e-06	5.02e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—malignant glioma	5.84e-06	4.97e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—malignant glioma	5.71e-06	4.86e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—malignant glioma	5.53e-06	4.71e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—malignant glioma	5.47e-06	4.66e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	5.45e-06	4.64e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.4e-06	4.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—malignant glioma	5.39e-06	4.59e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.37e-06	4.57e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—malignant glioma	5.35e-06	4.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—malignant glioma	5.33e-06	4.54e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—malignant glioma	5.32e-06	4.53e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—malignant glioma	5.27e-06	4.48e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—malignant glioma	5.22e-06	4.44e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—malignant glioma	5.15e-06	4.38e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—malignant glioma	5.12e-06	4.36e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—malignant glioma	4.98e-06	4.24e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	4.95e-06	4.22e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—malignant glioma	4.84e-06	4.12e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—malignant glioma	4.79e-06	4.08e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.75e-06	4.04e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—malignant glioma	4.64e-06	3.95e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—malignant glioma	4.52e-06	3.85e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—malignant glioma	4.45e-06	3.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.14e-06	3.53e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—malignant glioma	4.1e-06	3.49e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.05e-06	3.45e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.86e-06	3.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—malignant glioma	3.58e-06	3.05e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.27e-06	2.78e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—malignant glioma	3.15e-06	2.69e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—malignant glioma	2.67e-06	2.27e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.52e-06	2.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—malignant glioma	2.06e-06	1.76e-05	CbGpPWpGaD
